Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study

This post hoc subgroup analysis examined efficacy and safety outcomes with extended thromboprophylaxis rivaroxaban compared with in-hospital enoxaparin in 2,078 patients from the MAGELLAN study who had a hospitalization for heart failure or a history of heart failure and a lower risk of bleeding. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Spyropoulos, Alex C., Raskob, Gary E., Spiro, Theodore E., Lu, Wentao, De Sanctis, Yoriko, Albanese, John, Mebazaa, Alexandre, Barnathan, Elliot S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546607/
https://www.ncbi.nlm.nih.gov/pubmed/36299620
http://dx.doi.org/10.1055/a-1926-2489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546607/
https://www.ncbi.nlm.nih.gov/pubmed/36299620
http://dx.doi.org/10.1055/a-1926-2489

Ejemplares similares